Clinical trials
Phase 1 Lymphangioleiomyomatosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 2 |
| 2014 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brigham and Women's Hospital | 1 |
| Columbia University | 1 |
| M.D. Anderson Cancer Center | 1 |
| Peking Union Medical College Hospital | 1 |
| Tony Eissa | 1 |
| Vanderbilt University Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphangioleiomyomatosis | 6 |
| Breast Neoplasms | 1 |
| Carcinoma, Transitional Cell | 1 |
| Castleman Disease | 1 |
| Endocrine Gland Neoplasms | 1 |
| Erdheim-Chester Disease | 1 |
| Mouth Neoplasms | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms | 1 |
| Neoplasms, Mesothelial | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.